MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-11-0010192
Cent Cure Private Limited
Cent Cure Private Limited - pharma in Baddi, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹22.88 Cr
▲ 17% YoY
Net profit · FY 2025
₹22.31 Lakh
Net margin 1%
EBITDA · FY 2025
₹1.17 Cr
EBITDA margin 5.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹90.5 Lakh
Issued & subscribed
Open charges
₹5.16 Cr
Satisfied ₹4.87 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
1
Provident fund records
About Cent Cure Private Limited
Data last updated:
Cent Cure Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24299HP2018PTC006913. Its GSTIN is 02AAHCC4657P1ZB (Himachal Pradesh).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹90.5 Lakh. It is led by directors including Hitesh Garg and Sat Pal Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 71 Industrial Area, Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.88 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹22.31 Lakh (net margin 1%) and EBITDA of ₹1.17 Cr (EBITDA margin 5.1%).
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.16 Cr and satisfied charges of ₹4.87 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 4 cases are pending.
Cent Cure Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0010192).
Company details
CIN U24299HP2018PTC006913
Registration Number 006913
Incorporation Date 15 March 2018
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-HP-11-0010192
Recognitions & Rankings of Cent Cure
Contact details
Cent Cure Private Limited's registered office is in Baddi, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 71 Industrial Area, Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cent Cure Private Limited, buy the company report.
Comprehensive company report
Cent Cure Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cent Cure is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cent Cure Private Limited, buy the company report.
Financials of Cent Cure Private Limited
FY 2025 filings availableCent Cure Private Limited reported revenue of ₹22.88 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹22.88 Cr ▲ 17%
Net profit · FY 2025
₹22.31 Lakh margin 1%
EBITDA · FY 2025
₹1.17 Cr margin 5.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
EBITDA CAGR growth
1 year
▼ 16%
Revenue rose 17% in the latest year. EBITDA fell 16% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cent Cure Private Limited, buy the company report.
Board of directors of Cent Cure Private Limited
Cent Cure has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hitesh Garg | Director | 06 Sep 2023 | 3 Years 2 Months | Current |
| Amit Kumar | Additional Director | 24 Dec 2024 | 1 Years 10 Months | Current |
| Sat Pal Garg | Director | 15 Mar 2018 | 8 Years 7 Months | Current |
| Santosh Garg | Director | 15 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Cent Cure Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cerotic Healthcare Private Limited | ₹22.98 Cr (FY 2024) | 52.0% | Ghaziabad, Uttar Pradesh, India | |||
| Navil Laboratories Pvt Ltd | ₹22.93 Cr (FY 2024) | -15.0% | Ahmedabad, Gujarat, India | |||
| Orchid Bio-Tech Limited | ₹22.9 Cr (FY 2025) | -15.0% | Delhi, India | |||
| Cent Cure Private Limitedthis company | ₹22.88 Cr (FY 2025) | ₹22.31 Lakh | 1% | 17.0% | 1 | Baddi, Himachal Pradesh, India |
| Inga Laboratories Private Limited | ₹22.8 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Franklin Laboratories India Pvt Ltd | ₹22.76 Cr (FY 2025) | -5.0% | Punjab, India | |||
| Wallace Laboratories Private Limited | ₹22.71 Cr (FY 2023) | 27.0% | Goa, India |
To see the full peer comparison of Cent Cure Private Limited, buy the company report.
Auditor
Cent Cure Private Limited is audited by GARG SANJEEV & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG SANJEEV & ASSOCIATES | FY 2024 | 011326N |
Shareholding
The shareholding of Cent Cure Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cent Cure Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.16 Cr
Satisfied charges
₹4.87 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Mar 2025 | 101079922 | Others | ₹5.08 Cr | Open | |
| 20 Aug 2018 | 100230686 | Indian Overseas Bank | ₹8 Lakh | Open | |
| 06 Jul 2021 | 100468192 | State Bank of India | ₹4.87 Cr | Satisfied |
To see the full charge records of Cent Cure Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Cent Cure Private Limited has 7 court cases on record: 2 filed by Cent Cure, 5 filed against it. 4 cases are pending and 3 are disposed.
Total cases
7
Filed by the company
2
Filed against the company
5
Pending
4
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 2 |
| District courts | 3 | 3 | 2 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (APPP) | Filed against the company | Pending |
| Bombay High Court | Court case (APL) | Filed against the company | Pending |
| District court, Amravati, Maharashtra | Court case (R.C.C.) | Filed against the company by State Govt. | Pending |
| District court, Chatra, Jharkhand | Court case (Drugs and Cosmetic Special Case) | Filed against the company by an individual | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Cent Cure Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cent Cure Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cent Cure Private Limited has a workforce of 1 employees on its EPFO records as of Mar 29, 2025, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
Employee growth
-85.71%
GST
Cent Cure has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAHCC4657P1ZB | Himachal Pradesh | Active | 24 Aug 2018 |
To see the full GST registrations and return filing status of Cent Cure Private Limited, buy the company report.
Recent activity
Cent Cure Private Limited has 5 board changes on record since 2018: 4 appointments and 1 cessation. The latest: Amit Kumar was appointed as Additional Director on 24 Dec 2024.
AGM
Cent Cure Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cent Cure Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with Others amounted to Rs. 5.08 Cr with Charge ID 101079922 was registered on 24 Mar 2025.
Charges
A charge registered on 06 Jul 2021 via Charge ID 100468192 with State Bank Of India was fully satisfied on 01 Mar 2025.
Appointed
Amit Kumar was appointed as Additional Director.
Ceased
Hitesh Garg ceased to be Additional Director.
Appointed
Hitesh Garg was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 4.87 Cr registered on 06 Jul 2021 with Charge ID 100468192 was modified on 18 Apr 2023.
Charges
A charge with State Bank Of India amounted to Rs. 4.87 Cr with Charge ID 100468192 was registered on 06 Jul 2021.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.08 Cr with Charge ID 100230686 was registered on 20 Aug 2018.
Appointed
Santosh Garg was appointed as Director.
Appointed
Sat Pal Garg was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Cent Cure is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 March 2018 (8+ years old) and is registered under CIN U24299HP2018PTC006913.
Cent Cure has 4 current directors:
- Hitesh Garg - Director
- Amit Kumar - Additional Director
- Sat Pal Garg - Director
- Santosh Garg - Director
The latest financial statements of Cent Cure on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Cent Cure is 02AAHCC4657P1ZB, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Cent Cure is U24299HP2018PTC006913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cent Cure has 7 court cases on record: 2 filed by the company and 5 filed against it. 4 are pending. Most are in the high courts.
Cent Cure was incorporated on 15 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Cent Cure by revenue are Cerotic Healthcare Private Limited, Navil Laboratories Pvt Ltd, Orchid Bio-Tech Limited, Inga Laboratories Private Limited, Franklin Laboratories India Pvt Ltd and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Kumar was appointed as Additional Director on 24 Dec 2024. Hitesh Garg ceased to be Additional Director on 29 Sep 2024. Hitesh Garg was appointed as Director on 06 Sep 2023. Cent Cure has 5 board changes on record in total.
Yes, Cent Cure is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0010192).
The registered office of Cent Cure is at Plot No. 71 Industrial Area, Baddi, Himachal Pradesh, India – 173205.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages